BioPharma Credit (LON:BPCR - Get Free Report) shares reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 0.91 ($0.01) and last traded at GBX 0.91 ($0.01), with a volume of 394539 shares trading hands. The stock had previously closed at GBX 0.91 ($0.01).
BioPharma Credit Trading Up 0.2%
The company has a 50 day moving average of GBX 0.87 and a 200 day moving average of GBX 0.87. The firm has a market cap of £1.07 billion, a price-to-earnings ratio of 10.25 and a beta of 0.22.
BioPharma Credit Cuts Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, May 7th. Stockholders of record on Thursday, April 3rd were issued a dividend of $0.02 per share. This represents a dividend yield of 1.99%. The ex-dividend date of this dividend was Thursday, April 3rd. BioPharma Credit's dividend payout ratio (DPR) is presently 7,957.15%.
BioPharma Credit Company Profile
(
Get Free Report)
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.
See Also
Before you consider BioPharma Credit, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioPharma Credit wasn't on the list.
While BioPharma Credit currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
